Topic Listing for HOSPIRA

Aasb 119 Employee Benefits Aasb 121 Effects Changes Foreign Exchange Rates
Aasb 132 Financial Instruments Disclosure Presentation 139 Recognition Aasb 136 Impairment Assets
Aasb 138 Intangible Assets Aasb Business Combinations
Abbott Conversion Awards Abbott Legacy Compensation
Abn Amro Abn Amro Bank
Acceptance Notice Assignment Accumulated Other Comprehensive Income Loss
Accumulated Other Comprehensive Loss Accumulated Other Comprehensive Loss Income
Acquired Debt Acquired In-process Research Development
Acquisition Acquisition Consummated Integration Mayne Pharma Hospiras Operations Present
Acquisition Controlled Entities Acquisition Controlled Entities Businesses
Acquisition Creates Worlds Leader Specialty Generic Injectable Pharmaceuticals Acquisition Dispositions
Acquisition Integration-related Charges Acquisition Integration-related Expenses
Acquisition Mayne Pharma Acquisition Mayne Pharma Limited
Acquisition Supergen Oncology Products Acquisitions
Acquisitions Disposals Acquisitions Dispositions
Acquisitions Increased Hospiras Investment Balances Intangible Assets Goodwill Acquisitions Increased Investment Balances Decline Value Those Investments
Acquisitions Other Investment Activity Action Without Meeting
Actions Actuarial Assumptions
Addition Interest Each Loan Shall Payable Prepayment Such Addition Sarbanes-oxley Blackout Please Remember Hospira Observes Regularly
Additional Documents Additional Interest Libor Rate Loans
Adjournment Notice Adjourned Meetings Adjustments
Administration Administrative Agent
Admission Ticket Adoption New Accounting Standards
Adverse Market Conditions Affect Hospiras Ability Meet Future Advisors
Affected Lender Affected Loans
Affidavit Mailing Affiliate
Affirmative Covenants Affirms Sales Projection Narrows Earnings Guidance Upper End
Agency Fee Letter Agents
Agents Entitled Act Lenders Aggregate Amounts Due
Agreement Agreement Other Loan Documents Except Capacity Applicable Lender
Agreement Regarding Change Control Agreement Regarding Change Control Alternative Dispute Resolution Procedures
Agreement Regarding Change Control Forfeiture Provision Referenced Aguadilla Manufacturing Facility
Alejandro Infante Allowance Doubtful Accounts
Alternative Currency Alternative Currency Loan
Alternative Currency Sublimit Amend
Amendment Credit Agreement Amendment Directors Fee Plan
Amendment Discontinuance Amendment Material Definitive Agreement
Amendment Modification Amendment Termination
Amendments Amendments Articles Incorporation Bylaws
Amendments Articles Incorporation Bylaws Change Amendments Waivers
Amortisation Impairment Charge Amortization Mayne Pharma Intangible Assets
Annual Cash Incentive Annual Incentives
Annual Meeting Shareholders Annual Meetings
Annual Performance Evaluation Annual Transition Reports Pursuant Sections Securities Exchange Act
Anti-bribery Laws Applicable Currency
Applicable Law Applicable Margin
Applicable Reserve Requirement Application Prepayments Reductions
Application Sfas 158 2006 Application Sfas 158 2008
Appointment Appointment Principal Officer
Approval Lenders Approved Fund
Arrangements Abbott Asia Pacific
Asset Sale Assets Held Sale
Assignment Agreement Assignment Agreement Register Shall Give Prompt Notice Thereof
Associated Entities Associates
Assuming Lender Assumption Agreement
Assumptions Concerning Funding Libor Rate Loans Attend Meeting
Audit Committee Audit Fees
Audit Public Policy Committee Audit-related Fees
Authority Credit Parties Authority Responsibilities
Authority Responsibilities Relating Audit Issues Authority Responsibilities Relating Compensation
Authority Responsibilities Relating Public Policy Issues Authorization Borrowing Etc
Authorizations Consents Authorized Signatures Completed Vote Counted Date Sign Below
Availability Funds Available
Available Amount Available Sale Securities
Available-for-sale Financial Assets Available-for-sale Financial Investments
Available-for-sale Investments Award Forms
Awards Background
Backlog Bank Overdraft
Bankruptcy Code Bankruptcy Etc
Base Rate Base Rate Loan
Base Salary Basic Prospectus
Basis Consolidation Basis Preparation
Basis Presentation Basis Presentation Accounting Policies
Beneficial Ownership Reporting Compliance Benefit Plan Changes
Benefits Bidder Information
Binding Obligation Bioceuticals
Biologici Italia Laboratories Blackout Period Begin Central Time 2007 End
Board Directors Recommends Vote Election Nos Board Directors Recommends Vote Matters Described Above
Bonus Shares Stock Units Booking Libor Rate Loans
Books Records Borrower
Borrower Commercial Paper Debt Borrowing
Borrowing Costs Borrowing Mechanics
Breach Certain Covenants Breach Representation Warranty
Break Fee Bresagen Acquisition
Bresagen Investment Brian Smith
Bridge Facility Bridge Loan Agreement
Building Foundation Biosimilars Business
Business Acquisitions Business Development Projects
Business Overview Business Strategy
California Proposition Canadian Prime Rate
Canadian Subsidiary Cancellation Debt Facility
Cancellation Share Options Capital Adequacy Adjustment
Capital Debt Restructure Capital Lease
Capital Stock Capitalisation Development Costs
Capitalized Interest Capitalized Software Costs
Cash Equivalents Cash Flow
Cash Flow Hedges Cash Funding
Cash Funding Benefit Payments Cause Waiting Period Extensions Thereof Hsr Act Terminate
Caution Concerning Forward-looking Statements Cdor Rate
Ceo Long-term Equity Compensation Certain Calculations
Certain Calculations Respect Period Permitted Acquisition Asset Sale Certain Definitions
Certain Other Permitted Assignments Certain Regulatory Matters
Certain Relationships Related Transactions Certain Relationships Related Transactions Director Independence
Certificate Non-bank Status Certification Chief Executive Officer Required Rule 13a-14 Cfr
Certification Chief Financial Officer Required Rule 13a-14 Cfr Certification Pursuant Usc 1350 Adopted 906 Sarbanes-oxley Act
Cgmi Change Accounting Policy
Change Control Change Control Agreement
Change Control Agreements Change Control Agreements Severance Pay
Change Control Severance Pay Changes
Changes Accountants Changes Buying Patterns Some Hospiras Customers Adversely Affect
Changes Disagreements Accountants Accounting Financial Disclosure Changes Funded Status Costs Hospiras Pension Post-retirement Benefit
Changes Funded Status Costs Pension Post-retirement Benefit Plans Changes Internal Controls
Changes Key Management Personnel Period After Reporting Date Charge Backs
Chargebacks Chargebacks Rebates
Chargebacks- Chris Kolber
Christopher Begley Citicorp
Claims Pari Passu Class Directors Whose Terms Expire 2006
Class Directors Whose Terms Expire 2007 Class Directors Whose Terms Expire 2008
Class Directors Whose Terms Expire 2009 Class Directors Whose Terms Expire 2010
Class Directors Whose Terms Expire 2011 Class I-nominees Term Expiring 2008
Classes Directors Closing Date
Closure Aguadilla Manufacturing Facility Collaboration Expected Result Introductions Biosimilar Erythropoietin Europe
Comfort Letters Commercial Commitments
Commercial Operations Commitment
Commitment Increase Commitment Letter
Commitments Committee
Committees Board Directors Common Stock
Communicating Board Directors Communications
Comparison Cumulative Total Return Compelling Strategic Rationale
Compensation Compensation Breakage
Compensation Committee Compensation Committee Report
Compensation Discussion Analysis Compensation Increased Costs Taxes
Competing Bidder Competing Proposal
Competition Completion Acquisition Disposition Assets
Completion Acquisition Hospira Inc Compliance Certificate
Compliance Laws Components Remuneration
Computation Interest Computation Interest Reimbursement Obligations
Computer Software Concentration Risk
Conditions Effectiveness Conditions Precedent
Conditions Precedent Each Commitment Increase Extension Date Conditions Precedent Each Credit Extension
Conduct Business Confidentiality
Confidentiality Agreement Conflict
Connie Curran Edd Consent Independent Registered Public Accounting Firm
Consent Jurisdiction Service Process Consolidated Adjusted Ebit
Consolidated Adjusted Ebitda Consolidated Financing Expense
Consolidated Net Income Consolidated Net Worth
Consolidated Total Debt Contacts
Contingencies Guarantees Contingent Consideration
Continuing Director Continuing Directors
Continuing Guaranty Contract Manufacturing
Contractual Commitments Contractual Obligation
Contractual Obligations Contractual Obligations Off-balance Sheet Arrangements
Contributed Equity Controls Procedures
Conversion Amounts Applicable Currencies Conversion Continuation
Conversion Continuation Date Conversion Continuation Notice
Corporate Governance Materials Cost Reduction Activities
Cost-reduction Activities Cost-reduction Optimization Activities
Costs Associated Exit Disposal Activities Counterparts Effectiveness
Court Court Date
Creation Direct Financial Obligation Creation Direct Financial Obligation Off-balance Sheet Arrangement
Credit Agreement Guaranty Credit Exposure
Credit Organizational Documents Credit Party
Credit Pursuant Documentation Reasonably Satisfactory Administrative Agent Amounts Credit Risk
Critical Accounting Judgements Applying Consolidated Entitys Policies Critical Accounting Policies
Critical Care Devices Cumulative Translation Adjustments
Currency Currency Agreement
Currency Loan Business Prior Date Such Dollar Amount Current Tax
Current Tax Liabilities Restated Curtailment Post-retirement Medical Dental Benefits
Cusip Cusip 441060 Ah3
Cusip 441060 Aj9 Customers Sales Distribution
Customs Export Anti-boycott Laws Customs Laws
Cut Off Date Data Room
Date Receipt Shareholder Proposals 2006 Annual Meeting Proxy Date Receipt Shareholder Proposals 2007 Annual Meeting Proxy
Date Receipt Shareholder Proposals 2008 Annual Meeting Proxy Date Receipt Shareholder Proposals 2009 Annual Meeting Proxy
Debt Debt Capital
Debt Covenants Debt Issuance
Declaration Dividends Deed Poll
Deemed Earnings Account Balances Deemed Refer Other Matters Fall Within Broadest Possible
Default Default Excess
Default Other Agreements Default Period
Default Rate Defaulted Loan
Defaulting Lenders Deferral Contributions Payment Elections
Deferred Actuarial Gains Losses Defined Benefit Fund Assumptions
Defined Benefit Plans Defined Contribution Plans
Defined Contribution Superannuation Funds Defined Terms
Delaware Delegation Authority
Delivery Deloitte Touche Llp
Demerger Mayne Pharma Limited Departure Director
Departure Directors Departure Directors Certain Officers Election Appointment Compensatory
Departure Directors Certain Officers Election Appointment Compensatory Arrangements Departure Directors Principal Officers Election Appointment
Departure Directors Principal Officers Election Appointment Officer Deposit Account
Depreciation Impairment Charge Derecognition Disposal
Derecognition Financial Assets Liabilities Derivative Financial Instruments Hedging
Derivatives Description Business
Description Performance Incentive Plan Description Plans
Development Costs Did Receive Notice Mail Regarding Internet Availability Proxy
Did Receive Proxy Statement Director Share Ownership Guidelines
Directors Directors Corporate Governance
Directors Covered Directors Executive Officers Corporate Governance
Directors Officers Disclosed Litigation
Disclosure Disclosure Letter
Disposition Commitment Loans Interests Therein Shall Times Remain Dispute Resolution
Dissolution Distribution
Distribution Commencement Date Distribution Method
Dividend Declaration Dividend Reserve
Dividends Documentation Agents
Dollar Amount Dollars
Drawn Term Facility Drug Delivery Pumps
Drug Device Laws Due 2015
Duration Amendment Termination Duties Chief Executive Officer
Duties Chief Financial Officer Duties Corporate Vice Presidents
Duties Secretary Duties Senior Vice Presidents
Duties Treasurer Shall Administer Investing Financing Insurance Credit Earned Units Deferral
Earnings Per Share Earnings Per Share Calculations Presented Below Been Prepared
Economic Development Promissory Notes Edward Ogunro Phd
Effect Acquisitions Effect Assignment
Effective Effective Date
Effective Date Deferral Changes Elect Receive Future Proxy Statements Annual Reports Electronically
Election Directors Elective Deferrals
Eligibility Eligibility Participation
Eligible Assignee Emea
Employee Benefit Plan Employee Benefit Plans
Employee Benefits Agreement Employees
Employer Contributions Enactment Minimum Share Ownership Guidelines
Enforcement Enhances Orchids Financial Flexibility Pursue New Growth Opportunities
Entry Material Definitive Agreement Environmental Claim
Environmental Laws Environmental Protection
Equity Equity Compensation Plan Information
Equity Securities Erisa
Erisa Affiliate Erisa Event
Erisa Litigation Establishment Purposes
Establishment Trust Estimates
Euro Evaluating Non-strategic Assets
Evaluation Evaluation Disclosure Controls Procedures
Even Though Final Performance Earns Cumulative Payout Grantee Events
Events Default Evidence Insurance
Exception Subsidiary Borrowers Exchange Act
Excluding Special Identified Hospiras Quarterly Annual Earnings Releases Exculpatory Provisions
Execution Corporate Instruments Execution Other Securities
Executive Committee Executive Compensation
Executive Director Specified Remuneration Executive Officers
Executive Officers Hospira Executive Remuneration Policy
Executive Share Retention Ownership Guidelines Executive Summary
Exhibits Existence
Expand Solidify Hospiras Oncology Presence Expense Associated Epirubucin Litigation
Expenses Expenses Associated Examination Possible Listing London Stock Exchange
Expenses Associated Hospira Transaction Explanation Material Adjustments Cash Flow Statement
Explanation Transition Aifrs Explanatory
Explanatory Memorandum Extension Date
Extension Maturity Date Facilities
Facilities Optimization Charges Facilities Restructuring Optimization Charges
Facility Fee Factors Influence Results Operation
Factors Influence Results Operations Failure Effectively Manage Efforts Product Collaboration Agreements Harm
Failure Make Payments Due Failure Receive Notice
Fair Value Hedges Fair Value Measures
Fair Values Faulding Limited
Federal Funds Effective Rate Fee Letter
Fees Compensation Fees Independent Registered Public Accountants
Fees Payable Directors Field Drive
Field Drive Lake Forest Illinois 60045 Filed Securities Exchange Incorporated Reference Hospira Undertakes Obligation
Final Awards Finance Lease Liabilities
Financial Assets Financial Assets Carried Amortised Cost
Financial Assets Carried Cost Financial Assets Fair Value Through Profit Loss
Financial Condition Financial Condition Credit Parties
Financial Covenants Financial Information
Financial Instrument Risk Management Financial Instruments Derivatives
Financial Liabilities Financial Operating Review
Financial Results Financial Risk Management Objectives Policies
Financial Statements Exhibits Financial Statements Foreign Operations
Financial Statements Other Reports Financial Statements Projections
Financial Summary Financials
Financing Activities Fixed Annual Remuneration Far
Fixing Record Dates Floating Rate Due 2010
Food Drug Laws Foreign Currency
Foreign Currency Sensitive Financial Instruments Foreign Currency Transactions
Foreign Exchange Derivatives Foreign Exchange Risk
Form Form 10-k
Form 10-q Form Execution Certificates
Forward-looking Statements Freezing Plans
Full-year 2004 Results Full-year 2005 Results
Fund Funding Default
Funding Payment Office Further Assurances
Gaap General
General Administration General Development Business
General Provisions General Provisions Regarding Payments
General Terms Generally
Goodwill Goodwill Amortization
Goodwill Intangible Assets Governance Public Policy Committee
Government Authority Government Grants
Governmental Acts Governmental Authority
Governmental Authorization Governmental Authorizations
Governmental Consents Governmental Regulation
Governmental Regulation Other Matters Gpo Contracts
Grantor Trusts Gross Profit
Group Equity Guarantees
Guaranty Obligations Hazardous Materials
Hazardous Materials Activity Headings
Healthcare Fraud Abuse Laws Hedges
Hedges Net Investment Held-to-maturity Investments
Hereby Further Certify Effective Date Aforesaid Restated Certificate Highest Lawful Rate
Highlights Historical Financial Statements Mayne Pharma
Historical Long-term Incentive Entitlement Hospira
Hospira 401 Retirement Savings Plan Ability Trade Shares Hospira Acquire Other Businesses License Rights Technologies Products
Hospira Acquisition Mayne Pharma Clears Antitrust Review Hospira Announces Agreement Acquire Mayne Pharma
Hospira Announces Further Plans Optimize Manufacturing Operations Hospira Announces Plans Close Plant Donegal Ireland
Hospira Announces Plans Optimize Operations Increase Shareholder Value Hospira Appoints Terrence Kearney Newly Created Coo Position
Hospira Builds Information Technology Infrastructure Transitions Data Own Hospira Compensation Elements
Hospira Completes Acquisition Mayne Pharma Announces New Commercial Hospira Conduct Sales Activity Outside United States Subject
Hospira Conducts Sales Activity Outside Subject Additional Business Hospira Conducts Sales Activity Outside United States Subject
Hospira Contacts Hospira Continue Acquire Other Businesses License Rights Technologies
Hospira Depends Parties Supply Raw Materials Other Components Hospira Depends Success Product Collaboration Agreements
Hospira Expands Board Directors Hospira Expands Board Directors Page
Hospira Experience Higher Costs Produce Products Result Rising Hospira Experiencing Higher Costs Produce Products Result Rising
Hospira Faces Significant Competition Not Able Compete Effectively Hospira Icu Medical Sign Manufacturing Commercialization Development Agreement
Hospira Inc Hospira Inc Acquisition Mayne Pharma Limited
Hospira Inc Exact Name Regisrtant Specified Charter Delaware Hospira Inc Pro Forma Condensed Combined Financial Statements
Hospira Incur Product Liability Losses Insurance Coverage Inadequate Hospira Incur Significant Indebtedness Order Finance Acquisition Limit
Hospira Incur Substantial Charges Relating Mayne Pharma Acquisition Hospira Incur Substantial Charges Relating Pending Acquisitions
Hospira Incurred Continue Incur Significant Indebtedness Order Finance Hospira Incurred Significant Indebtedness Order Finance Mayne Pharma
Hospira Infringes Intellectual Property Rights Parties Face Legal Hospira Limited History Operating Independent Experience Increased Costs
Hospira Mednet System Hospira Names Thomas Werner Chief Financial Officer
Hospira Nominates Ronald Matricaria Wheeler Election Board Hospira Not Able Refinance Amounts Borrowed Bridge Loan
Hospira Not Introduce New Products Timely Manner Become Hospira Not Successfully Transition Operations Outside United States
Hospira Not Sufficient Funding Operating Capital Requirements Hospira Outstanding Stock Options Dilute Ownership Existing Shareholders
Hospira Relies Performance Information Technology Systems Failure Adverse Hospira Reports 2005 Results
Hospira Reports 2006 Results Hospira Reports 2006 Results Page
Hospira Reports 2007 Results Hospira Reports 2007 Results Page
Hospira Reports 2008 Results Hospira Reports 2009 Results
Hospira Reports Full-year 2004 Results Hospira Reports Full-year 2005 Results
Hospira Reports Full-year 2006 Results Hospira Reports Full-year 2007 Results
Hospira Reports Full-year 2008 Results Hospira Stada Bioceuticals Enter Agreements Erythropoietin
Hospira Subject Cost-containment Efforts Hospital Buying Groups Wholesalers Hospira Subject Cost-containment Efforts Wholesalers Distributors Customers Third-party
Hospira Subject Healthcare Fraud Abuse Regulations Result Significant Hospira Suppliers Customers Subject Various Governmental Regulations Costly
Hospira Unable Maintain Gpo Pricing Agreements Sales Products Hospira Unable Obtain Maintain Gpo Idn Pricing Agreements
Hospira Unable Protect Intellectual Property Rights Business Prospects Hospira Unable Protect Intellectual Property Rights Infringes Parties
Hospira Undertakes Obligation Release Publicly Revisions Forward-looking Statements Hospiras Cost Reduction Activities Resulted Significant Charges Disrupt
Hospiras Cost-reduction Activities Resulted Significant Charges Cash Expenditures Hospiras Cost-reduction Optimization Activities Resulted Continue Result Significant
Hospiras Credit Rating Been Downgraded Standard Poors Future Hospiras Credit Rating Was Downgraded Standard Poors 2007
Hospiras Credit Ratings Downgraded Current Levels Possible Fall Hospiras Historical Financial Information Not Indicative Future Results
Hospiras Indebtedness Subjects Various Restrictions Decrease Profitability Hospiras Manufacturing Capacity Limit Ability Expand Business Without
Hospiras Obligation Indemnify Abbott Liabilities Relating Business Burdensome Hospiras Pay-for-performance Philosophy
Hotel Pont Eleventh Market Streets Wilmington Delaware Hsr Act
I-95 North I-95 South
Icu Medical Identity Related Parties
Illegality Impracticability Libor Rate Loans Impairment
Impairment Assets Impairment Financial Assets
Impairment Goodwill Intangibles Indefinite Useful Lives Impairment Long Lived Assets
Impairment Long-lived Assets Impairment Long-lived Assets Facility Closure Costs
Impairment Losses Impairment Losses Asset Write Downs
Impairment Other Intangible Assets Implementation Date
Inability Determine Applicable Interest Rate Inc
Income Expense Associated Propofol Income Tax
Income Tax Expense Income Tax Expense Benefit
Income Taxes Income Taxes Unpredictable Effect Hospiras Results Operations Result
Income Taxes-hospiras Incorporation Documents Reference
Increase Aggregate Commitments Increase Date
Increases Earnings Projections 2005 Full Increases Earnings Projections 2006
Increases Sales Earnings Projections 2005 Full Increasing Lender
Increasingly Dependent Outsourcing Third-party Provider Arrangements Indebtedness
Indemnification Indemnification Directors Executive Officers Other Employees Agents
Indemnified Liabilities Indemnified Party
Indemnitees Indemnity
Indemnity Contribution Indentures
Independence Independence Covenants
Independent Expert Independent Experts Report
Index Index Consolidated Financial Statements Schedule
Index Exhibits Individual Directors Executive Compensation Disclosures
Industry Overview Ineligible Issuer
Information Technology Agreement Infusion Therapy Solutions Supplies
Initial Lenders Injectable Pharmaceutical Contract Manufacturing
Insolvency Event Insurance
Intangible Asset Measurement Intangible Assets
Integration Mayne Pharma Hospiras Operations Present Significant Challenges Integration-related Charges
Intellectual Property Matters Interest Coverage Ratio
Interest Expense Interest Expense Other Income Net
Interest Other Income Expense Net Interest Other Income Net
Interest Payment Date Interest Payments
Interest Period Interest Periods
Interest Periods Applicable Period Each Interest Rate Agreement
Interest Rate Agreements Currency Interest Rate Determination Date
Interest Rate Risk Interest Rate Sensitive Financial Instruments
Interest-bearing Liabilities Interest-bearing Loans Borrowings
Internal Restructuring Internal Restructuring Faulding
Internal Revenue Code Internal Revenue Code 162
International International Agreements
International Borrowings International Operations
Internet Information Intra-tech Healthcare Limited
Intralinks Introduction
Inventories Inventory Reserves
Investing Activities Investment
Investments Investments Accounted Using Equity Method
Investments Other Financial Assets Irving Bailey
Issuance Issued Capital
Issuer Purchases Equity Securities Issuing Bank
Jacque Sokolov John Staley
Joinder Agreement Joinder Date
Joinder Subsidiary Borrowers Joint Owners Stock
Joint Venture Joint Ventures
Jointly Controlled Entities Jointly Controlled Entity
Judgment Currency Judgments Attachments
Key Features Key Management Personnel Changes
Key Management Personnel Compensation Key Sources Estimation Uncertainty
Know Customer Laboratorios Farmaceuticos Rovi
Lake Forest Illinois 60045 Launches Project Fuel Improve Margins Drive Growth
Lead Arrangers Lead Director
Leases Leases Dollars
Legal Proceedings Legislative Issues
Lenders Lenders Evidence Debt
Lenders Purchase Participations Letters Credit Less
Letter Credit Letter Credit Drawings
Letter Credit Sublimit Letter Credit Usage
Letters Credit Leverage Ratio
Liability Guarantor Absolute Libor
Lien Liens
Liquidity Capital Resources Liquidity Capital Resources 2005 Compared 2004
Liquidity Capital Resources 2006 Compared 2005 Liquidity Capital Resources 2007 Compared 2006
Liquidity Capital Resources 2008 Compared 2007 Liquidity Capital Resources 2009 Compared 2008
Liquidity Risk List Stockholders
Litigation Litigation Compliance Laws
Loan Documents Loans Affected Currency Convert Libor Rate Shall Suspended
Loans Key Management Personnel Related Parties Loans Receivable
Loans Receivables Lock-up Period
Long Service Leave Long Term Incentive Lti
Long-lived Assets Long-term Compensation
Long-term Equity Compensation Long-term Incentives
Loss Contingencies Loss Contingencies-
Lost Certificates Maintenance Properties
Management Report Internal Control Over Financial Reporting Managers
Mandatory Prepayments Manufacture Hospiras Products Highly Exacting Complex Hospira Suppliers
Manufacture Supply Agreements Manufacturing
Manufacturing Facilities Manufacturing Optimization
Manufacturing Quality Map Directions
Margin Regulations Margin Stock
Market Common Stock Market Conditions
Market Data Used Benchmark Pay Marketable Securities
Marketing Pricing Cases Marshalling Payments Set Aside
Material Adverse Change Material Adverse Effect
Material Impairments Maturity Date
Maximum Stock Award Levels Mayne Group Limited Demerger Pharma
Mayne Pharma Mayne Pharma Acquisition
Mayne Pharma Acquisition Agreement Terminated Closing Conditions Not Mayne Pharma Acquisition Referred Expenses Including Reasonable Legal
Mayne Pharma Acquisition Well Certain Other Smaller Acquisitions Mayne Pharma Employee Share Plan Esp
Mayne Pharma Executive Share Option Plan Esop Mayne Pharma Information
Mayne Pharma Integration Mayne Pharma Limited Acquisition
Mayne Pharma Material Adverse Change Mayne Pharma Option
Mayne Pharma Prescribed Occurrence Mayne Pharma Senior Executive Short Term Incentive Plan
Mayne Pharma Share Register Mayne Pharma Shareholder
Media Medication Delivery Systems
Medication Management Systems Meeting
Meeting Room Government-issued Picture Identification Required Meetings
Methods Notice Michael Kotsanis
Minimum Consolidated Net Worth Minimum Pension Liabilities
Miscellaneous Mitigation
Modifications Agreement Other Loan Documents Agreements Relating Loans Mssf
Multi-currency Bank Debt Facility Multiemployer Plan
Myla Nauman Jane Roller Michael Loughery Abbott Laboratories Nationally Recognized Statistical Rating Organization
Nature Purpose Reserves Nature Tax Funding Arrangements Sharing Agreements
Negative Covenants Net Pension Medical Dental Benefit Cost
Net Sales Net Sales Comparisons Constant Currency Rates
New Commercial Leadership Structure Appointments Nine-month Results
Nominations Compensation Committee Nominee Election Class Director Term Expiring 2010
Nominees Nominees Election Class Directors 2007 Annual Meeting
Nominees Election Class Directors 2008 Annual Meeting Nominees Election Class Directors 2009 Annual Meeting
Non-consenting Lender Non-employee Director Restricted Stock Agreement
Non-exclusivity Rights Non-executive Director Remuneration
Non-executive Directors Share Plan Non-gaap Adjusted Financial Measures
Non-gaap Financial Measures Non-qualified Deferred Compensation Plan
Non-recurring Transition Expenses Non-us Lender
Nonqualified Deferred Compensation Plan Not Applicable
Notes Notes Reconciliation Financial Instruments Aasb 132 139 Was
Notice Annual Meeting Shareholders Held 2005 Notice Annual Meeting Shareholders Held 2007
Notice Annual Meeting Shareholders Held 2008 Notice Borrowing
Notice Deferral Election Form Notice Directors
Notice Hospira Shareholders Notice Issuance
Notice Meetings Notice Person Undeliverable Address
Notice Stockholders Notices
Notices Subsidiary Borrowers Now Conducted Proposed Enter Loan Documents Party Carry
Now Therefore Nqso Terms
Number 1-31946 Number Term Office
Obligations Obligations Absolute
Officers Certificate Officers Designated
Offices Onkoworks Gesellschaft Fuer Herstellung Und Vertrieb Onkologischer Spezialpraepararte
Operating Activities Operating Rights Licences
Operation Administration Operational Restructuring
Opinion Counsel Opinions Counsel
Optimizing Product Line Option Exercises 2006
Option Exercises 2007 Option Price
Options Orchid
Orchid Hospira Partnership Orchid Safe Harbour
Order Organization
Organization Powers Organization Powers Qualification Good Standing Business Subsidiaries
Organizational Documents Other
Other Borrowings Other Business
Other Commercial Commitments Other Committees
Other Defaults Loan Documents Other Devices
Other Events Other Factors
Other Fees Other Income Expense Net
Other Income Net Other Indebtedness
Other Information Other Key Management Personnel Transactions
Other Laws Other Loan Documents Accordance Instructions Requisite Lenders Such
Other Long-term Liabilities Other Pharmaceuticals
Other Products Other Regulation Disclosure
Other Taxes Other Termination Events
Other Unsecured Loans Outstanding Amounts
Overview Overview Amendments
Owed Incurred Imposed Account Person Alone Severally Jointly Ownership Certain Beneficial Owners
Ownership Directors Management Parent Loan Forgiveness
Pari Passu Part
Participations Passu
Patents Trademarks Other Intellectual Property Patriot Act
Pay Costs Expenses Proxy Solicitation Payment Account Balances
Payment Amounts Due Payment Borrower
Payment Performance Obligations Payment Taxes
Payment Taxes Claims Peer Group Market Data
Pension Benefits Pension Other Post-employment Benefits
Pension Plan Pension Plan Assets
Pension Plans Pension Post-retirement Benefits
Pension Post-retirement Benefits Dollars Pension Post-retirement Benefits-
Pensions Postretirement Benefits Performance
Performance Graph Performance Level
Performance Objectives Performance Share Awards
Performance-based Awards Permitted Foreign Credit Facilities
Person Pharma Subsidiaries Disclosure Letter Attached Implementation Agreement
Pharmaceuticals Business Philips
Phone 224-212-2962 Fax 224-212-3358 E-mail Dougowenshospiracom Pht Pharma Srl
Physiometrix Acquisition Plan Benefit Information
Plan Overview Plan Part Companywide Focus Improving Manufacturing Efficiencies Productivity
Plan Participation Please Refer Reverse Side Telephone Internet Voting Instructions
Please Vote Proxy Card Today Policy
Policy Regarding Related Person Transaction Approval Policy Statements
Post-retirement Benefits Potential Event Default
Potential Payments Involuntary Severance Powers
Powers Duties Specified Pre-approval Policy
Preferred Share Purchase Rights Preliminary Statements
Prepayment Price Adjustments
Pricing Term Sheet Prime Rate
Principal Accounting Fees Services Principles
Private Securities Litigation Reform Act 1995 Caution Concerning Private Securities Litigation Reform Act 1995- Caution Concerning
Private Securities Litigation Reform Act 1995-a Caution Concerning Pro Rata
Pro Rata Share Pro Rata Shares
Procedure Recommendation Nomination Directors Transaction Business Annual Meeting Proceeding Liabilities
Proceedings Proceeds
Proceeds Loans Product Acquisition
Product Development Product Development Expenditure
Product Development Manufacturing Products
Project Fuel Restructuring Optimization Charges Projections
Projections 2006 Property Equipment
Property Equipment Net Property Plant Equipment
Propofol Development Costs Proposal Election Directors
Proposal Ratification Independent Registered Public Accountants Proposed Conducted Enter Loan Documents Party Carry Out
Provide Hospira Potent Cytotoxic Manufacturing Research Development Capabilities Provided
Provides Sales Earnings Projections 2006 Provisions
Proxies Submitted Internet Telephone Received 1159 Eastern Time Proxy Hospira Inc Solicited Behalf Board Directors Annual
Proxy Solicited Behalf Board Directors Annual Meeting Shareholders Purchase Accounting Charges
Purpose Qualification Good Standing
Qualified Receivables Transaction Qualitative Quantitative Disclosures Market Risk
Quality Assurance Quantitative Qualitative Disclosures Market Risk
Quorum Voting Ratable Sharing
Rate Interest Type Loan Ratification Independent Registered Public Accountants
Raw Materials Raw Materials Components
Reaffirms 2006 Adjusted Earnings Per Share Guidance Reaffirms Projections 2005 Full
Rebates Rebates Promotional Other Credits
Rebates- Receivables Transaction Attributable Indebtedness
Receiving Materials Recent Accounting Pronouncements
Recently Issued Accounting Standards Recently Issued Adoption New Accounting Standards
Reclassification Reclassifications
Recoverability Development Costs Recoverability Investments
Recoverability Property Plant Equipment Recoverable Amount
Reductions Register
Registered Office Registered Stockholders
Registration Statement Regular Special Meetings
Regulation Regulation Disclosure
Reimbursement Borrower Amounts Drawn Paid Letters Credit Reimbursement Date
Related Agreements Relationship Abbott
Relationship Performance Remuneration Financial Release
Releases Indemnification Relocation Costs Associated Recruitment Transfer Overseas Specified Executives
Removal Removal Replacement Lender
Remuneration Committee Principles Reward Remuneration Directors Other Key Management Personnel
Remuneration Paid Remuneration Paid Directors
Repatriation Taxes Replacement Lender
Report Audit Committee Report Audit Public Policy Committee
Report Independent Registered Public Accounting Firm Representations Warranties
Representations Warranties Assignee Representative
Repudiation Obligations Required Rule 13a-14 Cfr 24013a-14
Requirements Research Development
Research Development Costs Resignation
Resignations Resolution Irs Tax Audit Benefit
Responsibility Certain Matters Responsibility Issuing Bank Respect Requests Drawings Payments
Responsible Officer Restricted Payment
Restricted Payments Restricted Stock
Restricted Stock Letter Agreement Restricted Stock Unit Award Agreement
Restricted Stock Unit Awards Restricted Stock Units
Restriction Fundamental Changes Asset Sales Restrictions
Restrictions Subsidiary Distributions Restructuring
Restructuring Costs Restructuring Impairment
Restructuring Plan Dollars Restructuring Provision
Results Geographic Segment Results Operations 2005 Compared 2004
Results Operations 2006 Compared 2005 Results Operations 2007 Compared 2006
Results Operations 2008 Compared 2007 Results Operations Financial Condition
Retirement Allowances Retractable Technologies
Retractable Technologies Inc Abbott Laboratories Revenue
Revenue Recognition Revenue Recognition-
Revoke Proxy Revolving Commitment
Revolving Commitments Revolving Credit Facility
Revolving Credit Facility Amendment Revolving Exposure
Revolving Loan Right Assign
Risk Factors Risks Related Proposed Pending Acquisitions
Risks Relating Hospiras Transition Abbott Spin-off Risks Relating Mayne Pharma Acquisition Related Transactions
Road Show Roger Hale
Role Executive Officers Management Compensation Decisions Ron Squarer
Ronald Matricaria Safety Health Laws
Salary Sale Facility
Sale Goods Sales Customers Distribution
Sales-type Leases Sales-type Leases Dollars
Sarbanes-oxley Act 2002 Saving Clause
Schedule Schedule 14a
Schedule Timetable Schedules
Scheme Scheme Implementation Agreement
Scheme Implementation Agreement 2006 Scheme Meeting
Science Technology Committee Seal
Secured Bank Loans Securities
Securities Act Securities Activities
Security Ownership Certain Beneficial Owners Management Related Stockholder Segment Geographic Information
Segment Information Segmental Reporting
Selling General Administrative Senior Notes
Senior Unsecured Notes Senior Unsecured Notes-mayne Pharma Acquisition
Separation Separation Distribution Agreement
Severability Share Issues
Share Options Share Repurchase
Share Repurchase Program Share-based Payment Transactions
Shared Services Agreement Shareholder Proposals 2010 Annual Meeting
Shareholders Equity Shares
Shares Except Per Share Amounts Shares Subject Plan
Short Term Incentive Sti Short-term Borrowings Long-term Debt
Short-term Senior Unsecured Credit Facility Signature
Signatures Significant Accounting Estimates Judgements Assumptions
Significant Accounting Policies Significant Events
Significant Events 2007 Significant Liability Distribution Hospira Stock Spin-off Determined Taxable
Significant Subsidiary Six-month Results
Solvency Assurances Solvent
Soon Practicable After Implementation Scheme Mayne Pharma Reasonable Sources Uses Funds
Special Meetings Specialty Injectable Pharmaceuticals
Specific Factors Influencing Remuneration Strategy Spin-off Abbott
Spot Rate Spot Rate Calculation
Stada Standby Letters Credit
State Federal Investigations Existing Future Lawsuits Relating Alleged State Hawaii Abbott Laboratories Inc
State Laws State Texas Rel Ven-a-care Florida Keys Inc Abbott
Statement Compliance Stock Based Compensation
Stock Exchange Listing Stock Option Awards
Stock Option Provisions Regarding Termination Employment Stock-based Compensation
Stock-based Compensation Expense Stock-based Compensation-
Streamlining Organizational Structure Subject Transaction
Submit Proxy Vote Kept Confidential Subordinated Indebtedness
Subordination Other Obligations Subsequent Event
Subsequent Events Subsidiaries
Subsidiaries Hospira Inc Subsidiary
Subsidiary Borrower Subsidiary Borrowers
Successors Successors Assigns
Summary 2005 Compensation Summary 2007 Terms Employment Named Executive Officers
Summary 2008 Terms Employment Named Executive Officers Summary 2009 Terms Employment Named Executive Officers
Summary Cash Flows Summary Financial Position
Summary Sources Uses Cash Summary Terms Employment
Superior Proposal Supplemental Financial Information
Supplemental Financial Information Dollars Survival Rights
Surviving Obligations Symbion Health Limited
Syndication Agents Table
Table Non Executive Directors Additional Fees Table Non-executive Directors Base Fees 2006 Financial
Table Value Options Granted Executive Directors Specified Executives Tabulating Certifying Votes Meeting
Take Advantage Strategic Opportunities Hospira Need Raise Additional Tax
Tax Consequences Tax Consolidation
Tax Fees Tax Sharing Agreement
Telephone Meetings Temporary Suspension Trading Registrants Employee Benefit Plans
Tenure Duties Officers Term
Term Loan Agreement Term Loan Bridge Facilities
Terminated Lender Termination Existing Credit Agreement
Termination Material Definitive Agreement Terms Condition Ordinary Shares
Terms Conditions Ordinary Shares Terms Defined Herein Unless Context Otherwise Requires Used
Terrence Kearney Thank Voting
Then Thomas Moore
Thomas Werner Tim Oldham Phd
Time Notices Deemed Given Time Sale Prospectus
Timetable Total Utilization Commitments
Total Utilization Revolving Commitments Trade Laws
Trade Other Payables Trade Other Receivables
Transaction Details Transaction Expected Accretive Cash Eps 2007
Transactions Key Management Personnel Transactions Shareholders Affiliates
Transfer International Net Assets Abbott Transfers
Transition Abbott Transition Marketing Distribution Services Agreements
Transition Services Agreements Translation Adjustments
Transportation Laws Treasury Stock
Triggering Events Trustee
Unallocated Costs Undertakes Obligation Release Publicly Revisions Forward-looking Statements Result
Underwriting Agreement Uniform Customs Practice Documentary Credits
United States Canada Unlawful
Unrecognised Deferred Tax Assets Unregistered Sales Equity Securities Proceeds
Unsecured Loans Unsecured Revolving Credit Facility
Updated 2005 Projections Usury Savings Clause
Utilization Fee Vacancies
Valentine Yien Vesting Plan Benefits
Voluntary Commitment Reductions Voluntary Prepayments
Vote Hold Shares Through Broker Bank Other Nominee Vote Hold Shares Through Broker Other Nominee
Vote Hold Shares Through Hospira 401 Retirement Savings Vote Internet
Vote Meeting Vote Over Internet Telephone Please Not Mail Card
Vote Person Vote Proxy
Vote Telephone Internet Available Votes
Voting Rights Voting Securities Owned Corporation
Wages Salaries Annual Leave Sick Waiver Irrevocable Meaning Not Modified Either Orally Writing
Waiver Jury Trial Waiver Notice
Washington 20549 Webcast
What Broker Non-vote Affect Voting Requirements What Constitutes Quorum
What Covered Annual Meeting What Happens Director Nominee Not Receive Votes Election
What Vote Required Approve Each Matter What Voted Annual Meeting
Wheeler Mph Whereas
Wind-down Berlex Agreement Withholding Taxes
Workers Compensation Workforce Impact
Working Capital 
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki